Skip to navigation Skip to content

News

Share

New Study Sheds Light on How Immune B Cells May Activate MS

September 6, 2018

Researchers from the University of Zurich and others report new findings on how immune system activity may get started in multiple sclerosis. They found that memory B cells (immune cells that normally help to fight infections) activate another type of immune cell called T cells, which are known culprits in immune attacks that result in brain and spinal cord damage in MS. The team also identified a protein produced by B cells that T cells react to. This study yields new information on the underlying mechanisms involved in MS, helps to explain how the disease-modifying treatment Ocrevus® (ocrelizumab, Genentech, which depletes B cells) might work, and reveals new targets for the development of better treatments to stop the nervous system damage that causes MS symptoms and progressive disability.

Read more about the study on Science Daily

Read the paper, available via Open Access in the journal Cell
 

About Multiple Sclerosis

Multiple sclerosis is an unpredictable disease of the central nervous system. Currently there is no cure. Symptoms vary from person to person and may include disabling fatigue, mobility challenges, cognitive changes, and vision issues. An estimated 1 million people live with MS in the United States. Early diagnosis and treatment are critical to minimize disability. Significant progress is being made to achieve a world free of MS.

Share


© 2022 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.